Arcosa, Inc. (ACA) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
46/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 9 wins, 3 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinACA / S&P 36.95% / 15.20% |
LoseACA / S&P 9.72% / 15.00% |
WinACA / S&P 430.85% / 50.40% |
| 2026-Q12/3 |
WinACA / S&P -0.12% / -4.33% |
LoseACA / S&P 8.53% / 11.30% |
WinACA / S&P 184.91% / 27.70% |
| 2025-Q42/3 |
WinACA / S&P 13.52% / 2.65% |
LoseACA / S&P 5.44% / 9.00% |
WinACA / S&P 121.99% / 13.40% |
| 2025-Q33/3 |
WinACA / S&P 8.13% / 8.12% |
WinACA / S&P 6.97% / 4.61% |
WinACA / S&P 14.83% / 13.45% |
| 2025-Q21/3 |
WinACA / S&P 12.51% / 10.94% |
LoseACA / S&P 2.65% / 4.83% |
LoseACA / S&P -37.54% / 10.63% |
| 2025-Q11/3 |
LoseACA / S&P -20.24% / -4.27% |
WinACA / S&P 6.86% / 4.98% |
LoseACA / S&P -45.55% / 10.57% |
| 2024-Q41/3 |
LoseACA / S&P 2.14% / 2.41% |
WinACA / S&P 11.35% / 5.25% |
LoseACA / S&P -41.41% / 6.15% |
| 2024-Q32/3 |
WinACA / S&P 13.67% / 5.89% |
WinACA / S&P 11.68% / 5.89% |
LoseACA / S&P -55.27% / 6.11% |
| 2024-Q21/3 |
LoseACA / S&P -2.79% / 4.28% |
WinACA / S&P 8.89% / 5.38% |
LoseACA / S&P -48.28% / 5.12% |
| 2024-Q10/3 |
LoseACA / S&P 3.96% / 10.56% |
LoseACA / S&P 4.48% / 5.71% |
LoseACA / S&P -49.39% / 5.59% |
| 2023-Q41/3 |
WinACA / S&P 15.02% / 11.69% |
LoseACA / S&P 2.90% / 6.81% |
LoseACA / S&P -35.32% / 7.78% |
| 2023-Q31/3 |
LoseACA / S&P -5.05% / -3.27% |
LoseACA / S&P -1.69% / 7.52% |
WinACA / S&P 186.83% / -5.03% |
| 2023-Q22/3 |
WinACA / S&P 20.16% / 8.74% |
LoseACA / S&P 0.84% / 9.50% |
WinACA / S&P 209.57% / -8.57% |
| 2023-Q12/3 |
WinACA / S&P 16.24% / 7.50% |
LoseACA / S&P 5.84% / 10.77% |
WinACA / S&P 279.61% / -15.69% |
| 2022-Q41/3 |
LoseACA / S&P -4.89% / 7.56% |
LoseACA / S&P 10.14% / 11.88% |
WinACA / S&P 252.45% / -17.99% |
| 2022-Q33/3 |
WinACA / S&P 23.29% / -4.88% |
WinACA / S&P 14.74% / 13.47% |
WinACA / S&P 41.38% / -1.41% |
| 2022-Q22/3 |
LoseACA / S&P -18.83% / -16.10% |
WinACA / S&P 16.55% / 13.71% |
WinACA / S&P 17.50% / 11.04% |
| 2022-Q11/3 |
WinACA / S&P 8.74% / -4.60% |
LoseACA / S&P 12.93% / 15.97% |
LoseACA / S&P -17.84% / 42.23% |
| 2021-Q40/3 |
LoseACA / S&P 5.14% / 11.03% |
LoseACA / S&P 5.21% / 15.00% |
LoseACA / S&P -34.40% / 96.40% |
| 2021-Q30/3 |
LoseACA / S&P -14.51% / 0.58% |
LoseACA / S&P 2.59% / 10.77% |
LoseACA / S&P -39.58% / 69.42% |
| 2021-Q20/3 |
LoseACA / S&P -9.68% / 8.55% |
LoseACA / S&P 1.37% / 6.58% |
LoseACA / S&P -34.16% / 51.81% |
| 2021-Q12/3 |
WinACA / S&P 18.59% / 6.17% |
WinACA / S&P 4.06% / -1.06% |
LoseACA / S&P -22.92% / 7.39% |
| 2020-Q43/3 |
WinACA / S&P 24.72% / 12.15% |
WinACA / S&P 11.44% / -3.72% |
WinACA / S&P -5.63% / -33.42% |
| 2020-Q32/3 |
LoseACA / S&P 4.61% / 8.93% |
WinACA / S&P 15.57% / -2.04% |
WinACA / S&P -1.64% / -27.10% |
| 2020-Q22/3 |
LoseACA / S&P 6.32% / 20.54% |
WinACA / S&P 17.56% / -0.46% |
WinACA / S&P 32.07% / -27.11% |
| 2020-Q13/3 |
WinACA / S&P -10.70% / -19.60% |
WinACA / S&P 19.60% / 3.47% |
WinACA / S&P 45.45% / -14.75% |
| 2019-Q43/3 |
WinACA / S&P 30.42% / 9.07% |
WinACA / S&P 18.93% / 5.36% |
WinACA / S&P 50.00% / 2.99% |
| 2019-Q31/3 |
LoseACA / S&P -8.96% / 1.70% |
WinACA / S&P 16.11% / 5.02% |
LoseACA / S&P ACA unavailable / 0.21% |
| 2019-Q22/3 |
WinACA / S&P 23.37% / 4.30% |
WinACA / S&P 12.47% / 6.64% |
LoseACA / S&P ACA unavailable / 8.65% |
| 2019-Q10/3 |
LoseACA / S&P 10.52% / 13.65% |
LoseACA / S&P ACA unavailable / 8.12% |
LoseACA / S&P ACA unavailable / 14.29% |
| 2018-Q40/3 |
LoseACA / S&P ACA unavailable / -13.52% |
LoseACA / S&P ACA unavailable / 9.05% |
LoseACA / S&P ACA unavailable / 18.23% |
| 2018-Q30/3 |
LoseACA / S&P ACA unavailable / 7.71% |
LoseACA / S&P ACA unavailable / 10.21% |
LoseACA / S&P ACA unavailable / 19.06% |
| 2018-Q20/3 |
LoseACA / S&P ACA unavailable / 3.43% |
LoseACA / S&P ACA unavailable / 9.03% |
LoseACA / S&P ACA unavailable / 14.46% |
| 2018-Q10/3 |
LoseACA / S&P ACA unavailable / -0.76% |
LoseACA / S&P ACA unavailable / 7.68% |
LoseACA / S&P ACA unavailable / 12.46% |
| 2017-Q40/3 |
LoseACA / S&P ACA unavailable / 6.64% |
LoseACA / S&P ACA unavailable / 7.03% |
LoseACA / S&P ACA unavailable / 13.82% |
| 2017-Q30/3 |
LoseACA / S&P ACA unavailable / 4.48% |
LoseACA / S&P ACA unavailable / 5.68% |
LoseACA / S&P ACA unavailable / 17.57% |
| 2017-Q20/3 |
LoseACA / S&P ACA unavailable / 3.09% |
LoseACA / S&P ACA unavailable / 4.83% |
LoseACA / S&P ACA unavailable / 17.74% |
| 2017-Q10/3 |
LoseACA / S&P ACA unavailable / 6.07% |
LoseACA / S&P ACA unavailable / 3.67% |
LoseACA / S&P ACA unavailable / 13.32% |
| 2016-Q40/3 |
LoseACA / S&P ACA unavailable / 3.82% |
LoseACA / S&P ACA unavailable / 2.09% |
LoseACA / S&P ACA unavailable / 7.05% |
| 2016-Q30/3 |
LoseACA / S&P ACA unavailable / 3.85% |
LoseACA / S&P ACA unavailable / 0.20% |
LoseACA / S&P ACA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ACA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 47.29% | 20.78% |
| Annualized return | 47.29% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ACA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 192.83% | 83.14% |
| Annualized return | 23.97% | 12.86% |
10Y · 2018-11-05 to 2026-08-27
| Metric | ACA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 413.15% | 319.30% |
| Annualized return | 17.77% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VALMONT INDUSTRIES INC (VMI) | United States | $8.988B | 22.19 |
| Proto Labs Inc (PRLB) | United States | $2.226B | 64.02 |
| INNOVATE Corp. (VATE) | United States | $0.102B | |
| TECHPRECISION CORP (TPCS) | United States | $0.053B | 108.37 |